Cue Biopharma
Latest round
- Seed
Last raised
- Jan 2017
Total raised
- $26M
Investors
- 1
About Cue Biopharma
Cue Biopharma, Inc.Founded in 2015 and headquartered in Boston, US, Cue Biopharma, Inc. focuses on innovative biologics for immune modulation.5 per share on NASDAQ.Cue Biopharma specializes in engineered biologics that target and activate specific immune cells to treat autoimmune and inflammatory diseases.07 mn.Cue Biopharma plans to expand its product portfolio by developing new biologics targeting autoimmune diseases and launching them by 2025.
Who invested in Cue Biopharma
1 investor across 2 rounds
See all investors in Cue Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cue Biopharma
Who invested in Cue Biopharma?
Cue Biopharma has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cue Biopharma raised?
Cue Biopharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cue Biopharma last raise money?
Cue Biopharma's most recent round on record is a Seed, in Jan 2017.
What does Cue Biopharma do?
Cue Biopharma is a biotechnology company.
Where is Cue Biopharma headquartered?
Cue Biopharma is headquartered in Boston, US.
Which VCs invest in companies like Cue Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cue Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cue Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.